期刊文献+

构建具有突变铜-锌超氧化物歧化酶绿色荧光真核表达载体 被引量:2

Establishing the eukaryon expression vector with mutation Cu/Zn superoxide dismutase and green fluorescence
下载PDF
导出
摘要 目的:构建一个具有特殊临床表型的肌萎缩侧索硬化症家系的突变铜-锌超氧化物歧化酶与有增强绿色荧光蛋白基因的pEGFP-N1融合的真核表达载体。方法:实验于2003-09/2005-01在第三军医大学全军免疫学研究所完成。通过RT-聚合酶链扩增突变铜-锌超氧化物歧化酶cDNA,应用基因重组技术,将得到的突变铜-锌超氧化物歧化酶cDNA克隆入荧光真核表达载体pEGFP-N1中,转化DH5α感受态细胞,用含卡那霉素LB培养基平板筛选转化菌,阳性重组子经EcoRⅠ与BamHⅠ双酶切分析、测序鉴定。结果:提取到纯度较高的总RNA,通过RT-聚合酶链和基因重组得到重组质粒,应用EcoRⅠ与BamHⅠ双酶切重组质粒,得到长约130bp和4.6Kb的两条带,前者为插入片段的长度,后者为pEGFP-N1载体本身的长度。测序也最终证实重组载体的方向及序列正确。结论:突变铜-锌超氧化物歧化酶cDNA成功地亚克隆至荧光真核表达载体pEGFP-N1中,获得突变铜-锌超氧化物歧化酶/pEGFP-N1重组质粒,从而为实时监测突变铜-锌超氧化物歧化酶基因在体内的表达和蛋白定位提供一个有用的工具载体。 AIM: To construct eukaryon expression vector, which was the amalgamation of mutation Cu/Zn superoxide dismutase (mSOD1) gene and pEGFP-N1 of enhanced green fluorescent protein gene, with a special clinical phenotyping and familial amyotruphic lateral sclerosis (FAIS). METHODS: The experiment was done in the Institute of Military Immunology, Third Military Medical University of Chinese PLA from September 2003 to January 2005. The mSOD1 gene was obtained by RT-PCR and was cloned into fluorescent eukaryotic expression vector pEGFP-N1 by genetic recombination technique. The vector DH 5or was transformed with competent cell. The conversion bacteria on LB medium plates with kanamycin were screened and EcoR Ⅰ and BamH Ⅰ restrictive analysis and sequence identified the positive recombinants. RESULTS: High purity RNA was obtained. The recombinant was obtained by RT-PCR and gene recombination. Two bands with the length of 130 bp and 4.6 Kb were obtained by EcoR Ⅰ and BamH Ⅰ restrictive analysis. The former was the length of insertion element. The latter was the length of vector pEGFP-N1. The direction and sequence of the recombination vector were correct after the test of DNA sequence. CONCLUSION: The mSOD1 gene is successfully subcloned to insert into pEGFP-N1 of fluorescent eukaryon expression vector. The recombination plasmid of mSOD1/pEGFP-N1 is obtained. Thus, a useful tool for real time monitoring the express of mSOD1 gene in vivo and localization of protein is provided.
出处 《中国临床康复》 CSCD 北大核心 2005年第29期58-59,共2页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献6

  • 1史树贵,廖平,潘登,李露斯.肌萎缩侧索硬化一家系报道[J].第三军医大学学报,2003,25(3):273-274. 被引量:8
  • 2史树贵,李露斯,陈康宁,刘昕.一个肌萎缩侧索硬化家系的SOD1基因突变[J].中华医学遗传学杂志,2004,21(2):149-152. 被引量:19
  • 3Guegan C, Przedborski S. Programmed cell death in amyotrophic lateral sclerosis.J Clin Invest 2003 ;111(2):153-61.
  • 4Kwok PY, Chen X. Detection of single nucleotide polymorphisms. Curr Issues Mol Biol 2003;5(2):43-60.
  • 5Browne SE, Bowling AC, Baik MJ, et al. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis.J Neurochem 1998;71(1):281-7.
  • 6Wiedau-Pazos M, Goto JJ, Rabizadeh S, et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271 (5248):515-8.

二级参考文献13

  • 1[1]Walker M P, Schlaberg R, Hays A P. Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients[J]. Ann Neurol,2001,49(2):249-53.
  • 2[2]Viehaber S, Kuns D, Winkler K, et al. Mitochindrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis[J]. Brain, 2000, 123(7): 1339-1348.
  • 3Orrell RW, Habgood JJ, Gardiner I, et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurolog
  • 4Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 362∶59-62.
  • 5Guegan C, Przedborski J. Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest, 2003, 111∶153-161.
  • 6Yuan J, Yankner BA. Apoptosis in the nervous system. Nature, 2000, 407∶802-809.
  • 7Johnson WG. Late-onset neurodegenerative diseases-the role of protein insolubility. J Anat, 2000, 196∶609-616.
  • 8Jacobson J, Jonsson PA, Andersen PM, et al. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn superoxide dismutase mutations. Brain, 2001,124∶1461-1466.
  • 9Ohi T, Saita K, Takechi S, et al. Clinical features and neuropathological fingings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase. J Neurol Sci, 2002, 197∶73-78.
  • 10Kim NH, Kim HJ, Kim M, et al. A novel SOD1 gene mutation in a Korean family with amyotrophic lateral sclerosis. J Neurol Sci, 2003, 206∶65-69.

共引文献20

同被引文献20

  • 1史树贵,李露斯,陈康宁,刘昕.一个肌萎缩侧索硬化家系的SOD1基因突变[J].中华医学遗传学杂志,2004,21(2):149-152. 被引量:19
  • 2胡俊,史树贵,李露斯,吴玉章,倪兵.变性高效液相色谱法在FALS突变位点检测中的应用[J].第三军医大学学报,2005,27(13):1374-1376. 被引量:1
  • 3史树贵,李露斯,刘昕,倪兵,陈康宁.一个肌萎缩侧索硬化家系D21S223微卫星位点遗传连锁分析[J].第三军医大学学报,2006,28(4):363-365. 被引量:2
  • 4[5]Velasco I,Velasco VMA,Salazar P,et al.Influence of serumfree medium on the expression of glutamate transporters and the susceptibility to glutamate toxicity in cultured cortical neurons.NeurosciRes.2003,71:811-818.
  • 5[6]Nelson R.Protein instability and altered folding associated with ALS.Lancet Neurol,2005,4:462.
  • 6[7]Bruijn LI,Houseweart MK,Kato S,et al.Aggregation and motor neuron toxicity of an ALS-liked SODlmutant independent from wild-type SOD1.Science,1998,281(5384):1851-1854.
  • 7[8]Pamphlett R,Kum-Jew S.Zinc in the spinal cord of a mutant SOD1 mouse model of ALS.Neuroreport,2003,14:547-549.
  • 8[9]Curti D,Rognoni F,Alimonti D,et al.SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation.Amyotroph Lateral Scler Other Motor Neuron Disord,2002,3:115-122.
  • 9[10]Orrell RW,Marklund SI.,deBelleroche JS.Familial ALS is associated with mutations in all exons of SOD1:a novel mutation in exon 3 (Gly72Ser).J Neurol Sci,1997,153:46-49.
  • 10[11]Bush A I.Is ALS caused by an altered oxidative activity of mutant superoxide dismutase? Na Neurosci,2002,5:919-920.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部